Atlas Arteria Group (ASX: ALX) share price is in focus after the company posted a statutory net loss after tax of $73.3 million for the first half of 2026, mainly due to non-operating costs, while underlying net profit after tax rose to $94.3 million, up 29% on the prior period.

What did Atlas Arteria report?

• Statutory net loss after tax: $(73.3) million (H1 2025: $73.3 million profit)
• Underlying net profit after tax: $94.3 million (up 29% from H1 2025)
• Proportional toll revenue: $917.5 million (down 3.9%)
• Proportional EBITDA: $702.6 million (down 3.6%)
• Operating free cash flow per security: 19.1 cps (down 1.5%)
• Interim distribution: 20.0 cps; full-year guidance reaffirmed at 40.0 cps

What else do investors need to know?

Atlas Arteria’s results were weighed down by one-off costs tied to settling the Chicago Skyway Ontario Teachers’ Pension Plan put option and costs related to the unsolicited takeover offer from IFM. Excluding these, the company’s operational results proved fairly resilient despite foreign exchange headwinds weighing on revenue and cash flow.

IFM’s takeover saw its stake in Atlas Arteria lift from 34.5% to 67.4%. The board says it remains committed to its strategy and is now engaging closely with IFM to deliver value for all securityholders. The company also completed extinguishing the Chicago Skyway put option, funded by new corporate debt.

Atlas Arteria reported progress on legislative reform in Virginia, where changes are set to streamline future rate cases for its Dulles Greenway business. There were also steady operational metrics across its European and North American assets.

What did Atlas Arteria management say?

Hugh Wehby, Chief Executive Officer, said:

Our results for H1 2026 were affected by a number of non-operating costs, as well as unfavourable foreign exchange movements. Excluding these items, the underlying performance of our businesses was stable. The IFM Takeover Offer was significant for Atlas Arteria and our securityholders. As a result of the Takeover Offer, IFM’s relevant interest is now around 67%, and the Boards and management remain focused on delivering value for all securityholders.

What’s next for Atlas Arteria?

Atlas Arteria reaffirmed its 2026 full-year distribution guidance of 40.0 cps, with the interim distribution set at 20.0 cps for payment in October 2026. The group says it will continue to align distributions with free cash flow, paying out 90–110% of free cash flow on a full-year basis.

Looking ahead, the company is focusing on optimising its global toll road portfolio, unlocking cash flow at the Dulles Greenway, and preparing for French concession retenders. Management will update 2027 distribution guidance with its February 2027 results.

Atlas Arteria share price snapshot

The Atlas Arteria share price has underperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a decline of almost 11%.

View Original Announcement

The post Atlas Arteria H1 2026 earnings: profit swings on one-offs, guidance held appeared first on The Motley Fool Australia.

More reading

• How much passive income can I earn off a $900,000 superannuation balance?
• 2 ASX shares with dividend yields above 8%
• These ASX 200 shares could generate $10,000 per year in passive income
• How much is needed in superannuation for $2,000 in weekly passive income?
• How much could a $400,000 ASX share portfolio pay in dividends?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Aurelia Metals Ltd (ASX: AMI) share price is in focus after the company posted a 69% surge in net profit and declared a fully franked final dividend of 1.0 cent for FY26.

What did Aurelia Metals report?

• Total revenue jumped 40% to $480.2 million
• EBITDA rose 55% to $189.2 million, with EBITDA margin up to 39.4%
• Net profit after tax increased 69% to $82.7 million
• Operating cash flow grew 10% to $142.8 million
• No drawn debt at year-end, with cash balance at $143.9 million
• Declared fully franked final dividend of 1.0 cent per share (approx. $17.2 million total distribution)

What else do investors need to know?

Aurelia Metals delivered higher gold and base metal production than the prior year, with group gold output at 50.4 thousand ounces, exceeding revised guidance. The company’s operating costs rose to $315.3 million, reflecting increased mining activity and the ramp-up at the Federation mine.

Development of the Great Cobar project continues on schedule, targeting first ore in 2028. The Peak Plant Expansion is progressing as planned, recently commissioning a new tailings thickener and advancing the Tertiary Ball Mill project to boost processing capacity.

Aurelia completed a major refinancing in June without drawing on any debt facilities, ensuring a robust financial position to support ongoing projects and the declared dividend.

What did Aurelia Metals management say?

Interim Chief Executive Officer Martin Cummings commented:

FY26 was a year of strong operational and financial performance for Aurelia, with material increases in EBITDA, net profit after tax and operating cash flows. Gold production exceeded the revised guidance range and all other metals were produced within guidance. Along with strong metal prices, these results supported robust margins and cash generation. This performance has enabled the Board to declare a fully franked dividend of 1 cent per share

Throughout the year, we continued to advance our growth strategy to lift mining rates and expand processing capacity. Development of Great Cobar remains on track for first production in FY28, while the Peak Plant Expansion projects continued with commissioning of the Tailings Thickener, and the continued progress of the Tertiary Ball Mill project. Together, these projects enable an increase in processing capacity from 800ktpa to 1.1 – 1.2Mtpa.

Aurelia is well positioned to continue delivering strong production while advancing its pipeline of growth opportunities across the Cobar Basin, supported by our recently completed refinancing and strong balance sheet.

What’s next for Aurelia Metals?

For FY27, Aurelia is guiding for gold production between 50,000 and 60,000 ounces and expects higher output across copper, zinc, and lead. Group operating costs are anticipated to increase as production ramps up, but unit costs should fall as the plant expansion comes online.

Medium-term, the company is focused on completing Great Cobar and the New Occidental Tailings Retreatment projects, which are expected to extend mine life and support stable production. Exploration spend is set to rise as new drilling platforms become available, particularly at Great Cobar.

Aurelia Metals share price snapshot

Over the past 12 months, Aurelia Metals shares have risen 89%, outperforming the All Ordinaries Index (ASX: XAO).

View Original Announcement

The post Aurelia Metals: FY26 profit surges, dividend announced appeared first on The Motley Fool Australia.

More reading

• Aurelia Metals appoints Steve Badenhorst as new CEO to lead next growth phase

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Ramsay Health Care Ltd (ASX: RHC) share price is under the spotlight after the company reported underlying net profit after tax (NPAT) up 22.9% and underlying EBIT up 11.8% for the twelve months to 30 June 2026.

What did Ramsay Health Care report?

• Underlying NPAT: $364.1 million, up 22.9% on FY25 (constant currency)
• Underlying EBIT: $1,162 million, up 11.8% (constant currency)
• Revenue: $18.6 billion, up 4.2% (constant currency)
• Final fully franked dividend: 48.5 cents per share; full year payout ratio 60.3% of underlying earnings (total 91 cps)
• Funding Group leverage: 1.83x, below the 2.5x target
• Underlying EPS: 151.0 cps, up 27%

What else do investors need to know?

Ramsay reported positive transformation momentum in its Australian hospital business, driven by activity growth, higher acuity cases, improved theatre use, and stronger cost management. Both UK and Australian businesses were net cash flow positive, while capital discipline delivered a 30bps improvement in Group EBIT margin to 6.2% and ROIC growth.

The company completed or progressed several strategic moves in FY26, including progressing the planned separation (demerger) of its 52.8% stake in Ramsay Santé. The proposed demerger is tracking towards a shareholder vote in late November 2026 and aims to allow greater focus on the core Australian hospital business.

What did Ramsay Health Care management say?

Ramsay Health Care’s CEO, Natalie Davis, said:

I am pleased that we are maintaining high patient NPS scores and clinical excellence in every region, building transformation momentum in the Australian business, and improving performance and capital returns across the Group. I would like to thank our incredible people and our clinicians who dedicate themselves to our patients and are the foundation of our success.

What’s next for Ramsay Health Care?

Looking ahead, Ramsay expects to report EBIT growth and further margin improvement in FY27, with ongoing focus on cost management, activity growth, and capital discipline. The company will finalise the acquisition of National Capital Private Hospital in September 2026, integrating it into the Ramsay network.

The planned demerger of Ramsay Santé remains a key milestone in the coming year. If approved, it will simplify reporting and sharpen Ramsay’s attention on its Australian and UK hospital operations. Investments in technology, “Big 5” hospital initiatives, and continued optimisation are expected to support the next phase of growth.

Ramsay Health Care share price snapshot

The Ramsay Health Care share price has outperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a gain of over 15%.

View Original Announcement

The post Ramsay Health Care FY26: Profit surges on transformation momentum appeared first on The Motley Fool Australia.

More reading

• Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares
• Buy, hold, sell: Ramsay Healthcare, Xero, Electro Optic Systems shares
• Why experts say Qantas and these ASX shares are sells

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.